JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
157 hedge funds and large institutions have $1.55B invested in Juno Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 52 increasing their positions, 48 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 159 → 157 (-2)
26% less call options, than puts
Call options by funds: $13.1M | Put options by funds: $17.7M
Holders
157
Holding in Top 10
3
Calls
$13.1M
Puts
$17.7M
Top Buyers
| 1 | +$92.5M | |
| 2 | +$18.6M | |
| 3 | +$16.4M | |
| 4 |
Goldman Sachs
New York
|
+$15.8M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$14.4M |
Top Sellers
| 1 | -$33.5M | |
| 2 | -$8.92M | |
| 3 | -$4.57M | |
| 4 |
Citigroup
New York
|
-$3.76M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$3.76M |